Advertisement

Defining the Role of Interneuron N-Methyl-D-Aspartate Receptors in Prefrontal Cortex Inhibition

  • Robert W. Greene
    Correspondence
    Address correspondence to Robert W. Greene, M.D., Ph.D., Peter O’Donnell Brain Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9070.
    Affiliations
    Peter O’Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 460
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Choi D.W.
        • Monyer H.
        • Giffard R.G.
        • Goldberg M.P.
        • Christine C.W.
        Acute brain injury, NMDA receptors, and hydrogen ions: Observations in cortical cell cultures.
        Adv Exp Med Biol. 1990; 268: 501-504
        • Olney J.W.
        • Labruyere J.
        • Wang G.
        • Wozniak D.F.
        • Price M.T.
        • Sesma M.A.
        NMDA antagonist neurotoxicity: Mechanism and prevention.
        Science. 1991; 254: 1515-1518
        • Coyle J.T.
        The glutamatergic dysfunction hypothesis for schizophrenia.
        Harv Rev Psychiatry. 1996; 3: 241-253
        • Krystal J.H.
        • Karper L.P.
        • Seibyl J.P.
        • Freeman G.K.
        • Delaney R.
        • Bremner J.D.
        • et al.
        Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
        Arch Gen Psychiatry. 1994; 51: 199-214
        • Javitt D.C.
        • Zukin S.R.
        Recent advances in the phencyclidine model of schizophrenia.
        Am J Psychiatry. 1991; 148: 1301-1308
        • Grunze H.C.
        • Rainnie D.G.
        • Hasselmo M.E.
        • Barkai E.
        • Hearn E.F.
        • McCarley R.W.
        • et al.
        NMDA-dependent modulation of CA1 local circuit inhibition.
        J Neurosci. 1996; 16: 2034-2043
        • Homayoun H.
        • Moghaddam B.
        NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.
        J Neurosci. 2007; 27: 11496-11500
        • Pafundo D.E.
        • Miyamae T.
        • Lewis D.A.
        • Gonzalez-Burgos G.
        Presynaptic effects of N-methyl-D-aspartate receptors enhance parvalbumin cell–mediated inhibition of pyramidal cells in mouse prefrontal cortex.
        Biol Psychiatry. 2018; 84: 460-470

      Linked Article